Rubber Journal Asia Materials
Detoxifying latex for safer work and play applications Studies say that latex-based products
The FDA said that aside from medical gloves, a wide range of latexbased products, from adhesive bandages a n d catheters to sanitary napkins and blood pressure monitoring cuffs, can potentially trigger allergies and may Dr Ranjit K Matthan of Vystar is at cause anaphylactic the helm of developing aluminium shock. Any user may hydroxide-treated latex be at risk, it added. To minimise the risk, the agency suggested using powderfree gloves with reduced protein content. Making latex products safer, a new technology product is offered. The Ultra Low Protein Lattices (ULPL) is developed by US-based Vystar Corporation, the exclusive creator of Vytex natural rubber latex (NRL), a raw material that features significantly reduced levels of the proteins inherent to NR latex. Recently, a presentation was delivered by Dr Ranjit K. Matthan, an internationally renowned latex and rubber expert, who has joined Vystar’s Board of Directors and as Research & Development Director. Dr Matthan has been a consultant to Vystar since 2008 and has played a significant role in the manufacturing scale up of reduced-protein Vytex in Malaysia and refining the R&D of manufacturing processes for applications using Vytex NRL, such as latex foam, condoms, adhesives, medical devices. In the session titled “Advances in Environmentally Friendly Ultra Low Protein Natural Rubber Specialty Latices” during the International Latex Conference 2015 held in August in Akron, Ohio, Dr Matthan revealed ongoing developments in the formulation of ULPL with reduced or no ammonia and nitrosamines. He said that these advances in aluminium hydroxide-treated ULPL properties and applications address concerns on volatile organic content and nitrosamines for some critical latex products, such as balloons, catheters, condoms, and other medical devices. In formulating ULPL, Dr Matthan has pooled his expertise along with Joseph John, Director of the Polymer Consultancy Services in Chennai, India; and Bill Doyle, CEO of Vystar. The main man in ULPL’s R&D, Dr Matthan has been an important figure in South Asia’s rubber industry since the 1970s. He is also a key proponent for NR sustainability via the Bangkokbased Asia Pacific Elastomer Science and Technology (APEST).
like gloves, medical devices and balloons can result in users falling ill. Find out why and what advances have been made to prevent this, in this report by Angelica Buan.
T
he milky sap derived from the rubber tree (Hevea brasiliensis), latex, is about 30-40% rubber and the rest is made up of resins, ash, sugar, water, and more than 200 types of proteins. Of this number, 13 are known to be allergens according to the American Latex Allergy Association (ALAA). In the US healthcare environment, allergy from latex is comparatively low at 1% of the general population of about 3 million, states ALAA. Risk groups are further categorised as healthcare workers (8-17%), who are frequently using latex gloves or products, and individuals who have had multiple surgeries or children who have spina bifda-related surgeries (68%), all of which can be mitigated through avoidance of exposure. Solving the dilemma with low-protein latex or a long time, allergic reactions to latex proteins resulted in decreasing use of latex-based products. This is especially in the healthcare environment where latex gloves are important barrier devices and allergic reactions are major concerns.
F
“…allergic reactions to latex proteins resulted in decreasing use of latex-based products..” Last year, the US Food and Drug Administration (FDA) issued guidance on latex product labelling. The agency had been equivocal with latex-free labels in products, for lack of existing tests that could determine the total absence of allergy-inducing proteins in natural rubber latex, and thus latex-free claims were misleading. 5 N OV E M B E R / D E C E M B E R 2 015
www.rubberjournalasia.com